Authors: Luo, Y Rockow-Magnone, SK Joseph, MK Bradner, J Butler, CC Tahir, SK Han, EKH Ng, SC Severin, JM Gubbins, EJ Reilly, RM Rueter, A Simmer, RL Holzman, TF Giranda, VL

Citation: Y. Luo et al., Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents, ANTICANC R, 21(1A), 2001, pp. 23-28